Form 4 for BMY Bristol Myers Squibb
Accepted 2021-08-03 00:00:00 ET · period of report 2021-07-30 · accession 0000014272-21-000193 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2021-08-03 | 2021-07-30 | BMY | VESSEY RUPERT | EVP, Research, Early Dev | M - OptEx | $58.49 | +151.0K | 42.5K | New | +$8.83M |
| DM | 2021-08-03 | 2021-07-30 | BMY | VESSEY RUPERT | EVP, Research, Early Dev | S - Sale+OE | $68.07 | -158.4K | 36.6K | -81% | -$10.78M |
| DM | 2021-08-03 | 2021-07-30 | BMY | VESSEY RUPERT | EVP, Research, Early Dev | M - OptEx | $0.00 | -151.0K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, $0.10 par value | 2021-07-30 | M | A | 24,134 | $61.34 | 132,277 | D | — | — | |
| 2 | Common | Common Stock, $0.10 par value | 2021-07-30 | M | A | 22,483 | $60.53 | 154,760 | D | — | — | |
| 3 | Common | Common Stock, $0.10 par value | 2021-07-30 | M | A | 15,879 | $55.52 | 170,639 | D | — | — | |
| 4 | Common | Common Stock, $0.10 par value | 2021-07-30 | M | A | 8,489 | $44.70 | 179,128 | D | — | — | |
| 5 | Common | Common Stock, $0.10 par value | 2021-07-30 | M | A | 8,489 | $47.81 | 187,617 | D | — | — | |
| 6 | Common | Common Stock, $0.10 par value | 2021-07-30 | S | D | 140,653 | $68.08 | 46,964 | D | — | — | (F2) 140,653 of the shares sold were to cover the exercise price and taxes in accordance with broker's procedures for sell-to-cover transactions. The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $68.00 to $68.165, inclusive. The reporting person undertakes to provide the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price. |
| 7 | Common | Common Stock, $0.10 par value | 2021-07-30 | M | A | 5,843 | $61.01 | 87,608 | D | — | — | |
| 8 | Common | Common Stock, $0.10 par value | 2021-07-30 | M | A | 2,905 | $54.20 | 90,513 | D | — | — | |
| 9 | Common | Common Stock, $0.10 par value | 2021-07-30 | M | A | 17,630 | $56.44 | 108,143 | D | — | — | |
| 10 | Common | Common Stock, $0.10 par value | 2021-07-30 | M | A | 29,489 | $63.41 | 81,765 | D | — | — | |
| 11 | Common | Common Stock, $0.10 par value | 2021-07-30 | M | A | 373 | $56.44 | 52,276 | D | — | — | |
| 12 | Common | Common Stock, $0.10 par value | 2021-07-30 | M | A | 1,454 | $54.20 | 51,903 | D | — | — | |
| 13 | Common | Common Stock, $0.10 par value | 2021-07-30 | M | A | 1,651 | $60.53 | 50,449 | D | — | — | |
| 14 | Common | Common Stock, $0.10 par value | 2021-07-30 | M | A | 6,305 | $63.41 | 48,798 | D | — | — | |
| 15 | Common | Common Stock, $0.10 par value | 2021-07-30 | S | D | 17,740 | $68.01 | 36,650 | D | — | — | (F1) The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $67.93 to $68.045, inclusive. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price. |
| 16 | Common | Common Stock, $0.10 par value | 2021-07-30 | M | A | 5,843 | $58.78 | 42,493 | D | — | — | |
| 17 | Derivative | Option (right to buy) | 2021-07-30 | M | D | 373 | $0.00 | 0 | D | $56.44 · — to 2026-05-02 | 373 Common Stock, $0.10 par value | (F4) All of the shares are currently exercisable. |
| 18 | Derivative | Option (right to buy) | 2021-07-30 | M | D | 8,489 | $0.00 | 8,491 | D | $44.70 · — to 2028-05-08 | 8,489 Common Stock, $0.10 par value | (F4) All of the shares are currently exercisable. |
| 19 | Derivative | Option (right to buy) | 2021-07-30 | M | D | 15,879 | $0.00 | 3,494 | D | $55.52 · — to 2028-01-29 | 15,879 Common Stock, $0.10 par value | (F4) All of the shares are currently exercisable. |
| 20 | Derivative | Option (right to buy) | 2021-07-30 | M | D | 22,483 | $0.00 | 0 | D | $60.53 · — to 2027-01-30 | 22,483 Common Stock, $0.10 par value | (F4) All of the shares are currently exercisable. |
| 21 | Derivative | Option (right to buy) | 2021-07-30 | M | D | 5,843 | $0.00 | 0 | D | $58.78 · — to 2025-05-04 | 5,843 Common Stock, $0.10 par value | (F4) All of the shares are currently exercisable. |
| 22 | Derivative | Option (right to buy) | 2021-07-30 | M | D | 6,305 | $0.00 | 0 | D | $63.41 · — to 2025-02-02 | 6,305 Common Stock, $0.10 par value | (F4) All of the shares are currently exercisable. |
| 23 | Derivative | Option (right to buy) | 2021-07-30 | M | D | 1,651 | $0.00 | 0 | D | $60.53 · — to 2027-01-30 | 1,651 Common Stock, $0.10 par value | (F4) All of the shares are currently exercisable. |
| 24 | Derivative | Option (right to buy) | 2021-07-30 | M | D | 1,454 | $0.00 | 0 | D | $54.20 · — to 2026-02-01 | 1,454 Common Stock, $0.10 par value | (F4) All of the shares are currently exercisable. |
| 25 | Derivative | Option (right to buy) | 2021-07-30 | M | D | 8,489 | $0.00 | 8,491 | D | $47.81 · — to 2028-07-30 | 8,489 Common Stock, $0.10 par value | (F4) All of the shares are currently exercisable. |
| 26 | Derivative | Option (right to buy) | 2021-07-30 | M | D | 29,489 | $0.00 | 0 | D | $63.41 · — to 2025-02-02 | 29,489 Common Stock, $0.10 par value | (F4) All of the shares are currently exercisable. |
| 27 | Derivative | Option (right to buy) | 2021-07-30 | M | D | 5,843 | $0.00 | 0 | D | $61.01 · — to 2025-11-09 | 5,843 Common Stock, $0.10 par value | (F4) All of the shares are currently exercisable. |
| 28 | Derivative | Option (right to buy) | 2021-07-30 | M | D | 2,905 | $0.00 | 0 | D | $54.20 · — to 2026-02-01 | 2,905 Common Stock, $0.10 par value | (F4) All of the shares are currently exercisable. |
| 29 | Derivative | Option (right to buy) | 2021-07-30 | M | D | 17,630 | $0.00 | 0 | D | $56.44 · — to 2026-05-02 | 17,630 Common Stock, $0.10 par value | (F4) All of the shares are currently exercisable. |
| 30 | Derivative | Option (right to buy) | 2021-07-30 | M | D | 24,134 | $0.00 | 0 | D | $61.34 · — to 2026-08-01 | 24,134 Common Stock, $0.10 par value | (F4) All of the shares are currently exercisable. |